New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without diabetes, said Juan Badimon, PhD.
Juan Badimon, PhD, FACC, FAHA
Advertisement
Juan Badimon, PhD, FACC, FAHA, is a professor of medicine and the director of the Atherothrombosis Research Unit at The Mount Sinai School of Medicine’s Cardiovascular Institute.
Articles by Juan Badimon, PhD, FACC, FAHA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups
4
Zanubrutinib Tops Rivals in Real-World CLL Survival Study
5